Company profile for 280Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

280Bio Inc. is building a drug candidate portfolio of innovative precision small molecule inhibitors targeting key pathways for the treatment of cancers with a significant unmet need. The company is advancing its development programs via a strategic collaboration with MD Anderson Cancer Center and a partnership with Yingli Pharma. 280Bio drug candidates are being developed for monotherapy and combinatorial treatment approaches...
280Bio Inc. is building a drug candidate portfolio of innovative precision small molecule inhibitors targeting key pathways for the treatment of cancers with a significant unmet need. The company is advancing its development programs via a strategic collaboration with MD Anderson Cancer Center and a partnership with Yingli Pharma. 280Bio drug candidates are being developed for monotherapy and combinatorial treatment approaches in solid tumors and hematologic malignancies. 280Bio is preparing for several of these drug candidates to enter the clinic in 2023.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
San Francisco Bay Area
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty